Zimbabwe has declined a substantial American healthcare agreement worth $367m (272 million pounds) spanning five years over the United States' insistence on sensitive information.
This rejection became public after a official document from December was disclosed, which showed President Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesman has since explained that the United States was seeking genetic material for scientific study and commercial purposes but was not willing to share the benefits from any future treatments.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged continued talks to find a deal suitable to both sides so the country's vital HIV programme can proceed.
Wider Context
This rejection comes after a comparable situation in neighbouring Kenya, where a high court blocked a similar deal with the US following legal challenges were raised about the safety of citizens' health data.
Since returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government deals to enhance openness and accountability.
Based on reports, 16 nations in Africa have to date signed similar agreements, representing over $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that might result from that provided information," he stated.
"In essence, our nation would provide the basic resources for medical research without any assurance that the end products would be accessible to our population should a future disease outbreak arise."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were disrupting structures previously set up through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage potential pandemics.
"This system is designed to ensure that when a country provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the capability to develop them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage ongoing dialogue with our American counterparts on how subsequent collaboration could be designed in a manner that honours the sovereignty and interests of each country."
Health Experts Reaction
A leading public health body said it understood the official position, but suggested that talks must proceed given that much of the country's HIV programmes were funded by external financing.
"If technical issues exist, including those involving information security or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it commented.
This impasse highlights the continuing tensions between accepting much-needed international aid and safeguarding local interests in an increasingly data-driven world.